Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Equity Investor

Julia Lee
May 16, 2018

Market Update

Julia Lee
May 10, 2018

Equity Investor 7 May

Julia Lee
May 8, 2018

Market Update

Julia Lee
April 26, 2018

Market Update

Julia Lee
April 26, 2018

Equity Investor 23 April 2018

Bell Direct
April 24, 2018

Market Update

Julia Lee
April 18, 2018

Equity Investor 16 April

Julia Lee
April 17, 2018

Market Update

Julia Lee
April 12, 2018

LIC video – understand the basics

Bell Direct
April 11, 2018